Alpha Diagnostic International, Inc. Anti-Mouse Frataxin (FXN) antiserum FXN11-S

Anti-Mouse Frataxin (FXN) antiserum General Information Friedrich ataxia (FA), a degenerative disease characterized by progressive ataxia and hypertrophic cardiomyopathy leading to premature death, is cause by a deficiency in frataxin (Fxn). Fxn (mouse 207 aa, human 210 aa major isoform A; alternatively trans SugApplications Most Antibodies are tested by ELISA and Western. Additional applications, such as IHC or IP may have been tested and will be listed in the product data sheets or published research papers using our products. Typically, antibodies are tested against the SugSecAntibodies http://4adi.com/comm erce/ccc2480-seconda ry-antibodies-rabbit .htm SpeciesReactivity Mouse SugNegativeControl Non-immune Rabbit IgG Cat# 20009-1 Form Antiserum Unpurified SugPositiveControl Recombinant or naturally purified proteins or cells of tissues expressing the protein under study can be used as positive controls for Western or IHC. Please review the ?General Information? tan under Product overview section. Control or blocking peptid Antigen A 20-aa peptide sequence (designated FXN11-P or control peptide) within the C-terminus of mouse FXN SpCrossreactivity The FXN11-P sequence is 94% conserved in human FXN. Antibody cross-reactivity in various species has not been studied For research use only, not for diagnostic or therapeutic use.